Form 4: Mesa Laboratories Inc /Co/ Director Receives Stock Grant
Insider Transaction (Form 4)
Mark Christopher Capone, a Director of Mesa Laboratories Inc /Co/, received 2,423 shares of common stock on September 9, 2026.
Summary
- Grant/award: acquired 2,423 Restricted Stock Units - 4 on September 9, 2026; holds 2,423 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Christopher Capone — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Grant/award | Restricted Stock Units - 4 | 2,423 | — | — | 2,423 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Grant/award (2,423 shares) |
Keywords
insider transaction, Form 4, MLAB, MESA LABORATORIES INC /CO/, neutral, Mark Christopher Capone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.